One-month of a low-energy diet, with no additional effect of high-protein, reduces Obstructive Sleep Apnea severity and improve metabolic parameters in obese males.
Study Goal
The researchers aimed to evaluate the effects of a low-energy, high-protein diet on OSA severity and metabolic parameters in obese men.
Results Summary
Both low-protein and high-protein diets led to significant weight loss and improvements in OSA severity and metabolic parameters, with no additional benefits from increased protein intake.
Population
Obese men with Obstructive Sleep Apnea (BMI ≥ 30 kg/m²).
Effective Dosage
Not specified
Duration
1 month
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
low-energy, high-protein diet | decrease | body mass | obese men with obstructive sleep apnea | -3.7 ± 2.0% for the LP group and -4.0 ± 1.5% for the HP group | observed in | #1 |
low-energy, high-protein diet | decrease | Body Mass Index | obese men with obstructive sleep apnea | - | observed in | #2 |
low-energy, high-protein diet | decrease | fat mass in kg | obese men with obstructive sleep apnea | - | observed in | #3 |
low-energy, high-protein diet | decrease | fat-free mass in kg | obese men with obstructive sleep apnea | - | observed in | #4 |
low-energy, high-protein diet | decrease | Apnea Hypopnea Index | obese men with obstructive sleep apnea | 54.0 ± 25.0 to 33.7 ± 31.7 in LP group; 39.7 ± 24.3 to 21.4 ± 25.9 in HP group | Significant improvements in | #5 |
low-energy, high-protein diet | decrease | Apnea-Hypopnea Index | obese men with obstructive sleep apnea | 38% and 46% in the LP and HP groups, respectively | Improvements of | #6 |
low-energy, high-protein diet | decrease | glucose | obese men with obstructive sleep apnea | - | reductions in | #7 |
low-energy, high-protein diet | decrease | insulin | obese men with obstructive sleep apnea | - | reductions in | #8 |
low-energy, high-protein diet | decrease | HOMA-IR | obese men with obstructive sleep apnea | - | reductions in | #9 |
low-energy, high-protein diet | decrease | triglycerides | obese men with obstructive sleep apnea | - | reductions in | #10 |
low-energy, high-protein diet | decrease | total cholesterol | obese men with obstructive sleep apnea | - | reductions in | #11 |
Increased protein intake during a short period of low-energy diet | no change | OSA severity | obese men | - | had no further beneficial effects on | #12 |
Increased protein intake during a short period of low-energy diet | no change | biochemical parameters | obese men | - | had no further beneficial effects on | #13 |
PURPOSE: Obstructive Sleep Apnea (OSA) is closely associated with obesity. Weight loss ameliorates OSA and its associated metabolic disorders. A high protein intake may improve weight loss through increased energy expenditure, and fat-free mass maintenance during weight loss. OBJECTIVES: To evaluate the effects of a low-energy, high-protein diet on OSA severity and metabolic parameters in obese men. METHODS: Forty-five OSA obese (BMI ≥ 30 kg/m RESULTS: Only a time effect of the intervention was observed in body mass (-3.7 ± 2.0% for the LP group and -4.0 ± 1.5% for the HP group; p < 0.001), Body Mass Index (p < 0.001), fat mass in kg (p < 0.01) and fat-free mass in kg (p < 0.01). Significant improvements in Apnea Hypopnea Index were observed in both groups (54.0 ± 25.0 to 33.7 ± 31.7 in LP group; 39.7 ± 24.3 to 21.4 ± 25.9 in HP group; p = 0.06). Improvements of 38% and 46% in the Apnea-Hypopnea Index were observed in the LP and HP groups, respectively. Both interventions provided equivalent metabolic benefits as reductions in glucose (p < 0.001), insulin (p < 0.001), HOMA-IR (p = 0.005), triglycerides (p = 0.002), and in total cholesterol (p = 0.004). CONCLUSION: One month of a low-energy diet resulted in significant improvements in OSA severity in obese men. Increased protein intake during a short period of low-energy diet had no further beneficial effects on OSA severity or biochemical parameters than a standard protein diet. Registered under ClinicalTrials.gov Identifier no. NCT01985035.